Bladder Cancer - Neoadjuvant Therapy with Cisplatin and Gemcitabine

被引：0
|
作者：
Schmid, Sebastian C. [1 ]
Gschwend, Juergen E. [1 ]
Retz, Margitta [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Urol Klin & Poliklin, D-80290 Munich, Germany
来源：
AKTUELLE UROLOGIE | 2013年 / 44卷 / 05期
关键词：
CHEMOTHERAPY; CYSTECTOMY;
D O I：
10.1055/s-0033-1356861
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：340 / 342
页数：5
相关论文
共 50 条
  • [1] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
    Narayan, Vivek
    Mamtani, Ronac
    Keefe, Stephen
    Guzzo, Thomas
    Malkowicz, S. Bruce
    Vaughn, David J.
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1084 - 1091
  • [2] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Xing, N.
    Han, S.
    Jiang, J.
    Xu, W.
    Shi, B.
    Ping, H.
    Ji, Z.
    Ma, Q.
    Wang, H.
    Chen, S.
    Wang, W.
    Fan, X.
    Zhou, Q.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
  • [3] Is paclitaxel, cisplatin, and gemcitabine (PCG) feasible as neoadjuvant therapy for locally advanced bladder cancer (LABC)?
    Exman, Pedro
    Correa, Tatiana Strays
    Rocha, Claudio Lima
    Barbosa, Caroline Chaul
    Dzik, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [5] Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder
    Scosyrev, Emil
    Messing, Edward M.
    van Wijngaarden, Edwin
    Peterson, Derick R.
    Sahasrabudhe, Deepak
    Golijanin, Dragan
    Fisher, Susan G.
    CANCER, 2012, 118 (01) : 72 - 81
  • [6] Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer
    Yang, Xiao
    Cao, Qiang
    Li, Pengchao
    Cai, Lingkai
    Zhuang, Juntao
    Lyu, Qiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer
    Niedersuess-Beke, Dora
    Puntus, Thomas
    Kunit, Thomas
    Gruenberger, Birgit
    Lamche, Michael
    Loidl, Wolfgang
    Bohm, Reinhard
    Kraischits, Nicole
    Kudlacek, Stefan
    Schramek, Paul
    Meran, Johannes G.
    ONCOLOGY, 2017, 93 (01) : 36 - 42
  • [8] Neoadjuvant cisplatin based therapy in bladder cancer: Is less enough?
    Abbasi, Saqib
    Al-Jumayli, Mohammed
    Hildebrand, Hannah
    Wulff-Burchfield, Elizabeth Marie
    Lee, Eugene K.
    Taylor, John A.
    Holzbeierlein, Jeffrey
    Martin, Grace
    Parikh, Rahul Atul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update
    Gupta, Shilpa
    Weight, Christopher J.
    Agarwal, Neeraj
    Gupta, Sumati
    Konety, Badrinath
    Gibb, Ewan
    Davicioni, Elai
    Thyagarajan, Bharat
    Sonpavde, Guru
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [10] Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Galsky, Matthew D.
    Pal, Sumanta K.
    Chowdhury, Simon
    Harshman, Lauren C.
    Crabb, Simon J.
    Wong, Yu-Ning
    Yu, Evan Y.
    Powles, Thomas
    Moshier, Erin L.
    Ladoire, Sylvain
    Hussain, Syed A.
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Recine, Federica
    Berthold, Dominik
    Necchi, Andrea
    Theodore, Christine
    Milowsky, Matthew I.
    Bellmunt, Joaquim
    Rosenberg, Jonathan E.
    CANCER, 2015, 121 (15) : 2586 - 2593
12345